FdaNdcDirectoryPulse / compare

BRYTLY vs Mybiooid Lidocaine 4% Pain Relieving Gel-Patch: FdaNdcDirectoryPulse comparison

BRYTLY (2026-10-16) and Mybiooid Lidocaine 4% Pain Relieving Gel-Patch (2026-10-14) are peer FdaNdcDirectoryPulse records.

Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does BRYTLY compare to Mybiooid Lidocaine 4% Pain Relieving Gel-Patch?

FieldBRYTLYMybiooid Lidocaine 4% Pain Relieving Gel-Patch
ProductBRYTLYMybiooid Lidocaine 4% Pain Relieving Gel-Patch
Generic nameApraclonidine HydrochlorideLidocaine 4% Pain Relieving Gel-Patch
NDC0065-859688068-001
LabelerAlcon Laboratories, Inc.Avelon Trading Limited
Product typeHUMAN OTC DRUGHUMAN OTC DRUG
Approval pathwayNDAOTC MONOGRAPH DRUG
Application numberNDA220341M017
Dosage formSOLUTION/ DROPSPATCH
RouteOPHTHALMICTOPICAL
Active ingredientsAPRACLONIDINE HYDROCHLORIDE 1.25 mg/mLLIDOCAINE 4 g/1001
Marketing start2026-10-162026-10-14
Package configurations32
Launch Signal Score45/10015/100
Peer rank and all 500 records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: BRYTLY · Mybiooid Lidocaine 4% Pain Relieving Gel-Patch

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.

Often used together